Phenomix Folds After Diabetes Drug Fails To Attract Partner To Fill Forest's Shoes
DPP-4 drug dutogliptin was a casualty of the highly competitive, regulated and expensive space for diabetes drug development.
DPP-4 drug dutogliptin was a casualty of the highly competitive, regulated and expensive space for diabetes drug development.